Mechanisms of Nanoparticle-Mediated siRNA Transfection by Melittin-Derived Peptides
Source abstract
Abstract
Traditional peptide-mediated siRNA transfection via peptide transduction domains exhibits limited cytoplasmic delivery of siRNA due to endosomal entrapment. This work overcomes these limitations with the use of membrane-destabilizing peptides derived from melittin for the knockdown of NFkB signaling in a model of adult T-cell leukemia/lymphoma. While the mechanism of siRNA delivery into the cytoplasmic compartment by peptide transduction domains has not been well studied, our analysis of melittin derivatives indicates that concurrent nanocomplex disassembly and peptide-mediated endosomolysis are crucial to siRNA transfection. Importantly, in the case of the most active derivative, p5RHH, this process is initiated by acidic pH, indicating that endosomal acidification after macropinocytosis can trigger siRNA release into the cytoplasm. These data provide general principles regarding nanocomplex response to endocytosis, which may guide the development of peptide/siRNA nanocomplex-based transfection.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Virus-based gene therapy research · Herpesvirus Infections and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Computational and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri. 63108, United States
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri. 63108, United States
Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri. 63108, United States
Department of Biomedical Engineering, Washington University School of Medicine, St. Louis, Missouri 63108, United States
References (71)
Show source-provided references
1. Shen H. · Cancer Gene Ther. · 2012 · 19 · 36710.1038/cgt.2012.22 ↗
2. Miele E. · Int. J. Nanomed. · 2012 · 2012 · 3637
3. Fire A. · Nature · 1998 · 391 · 80610.1038/35888 ↗
4. Elbashir S. M. · Nature · 2001 · 411 · 49410.1038/35078107 ↗
5. Dominska M. · J. Cell Sci. · 2010 · 123 · 118310.1242/jcs.066399 ↗
6. Guzman-Villanueva D. · J. Pharm. Sci. · 2012 · 101 · 404610.1002/jps.23300 ↗
7. Pecot C. V. · Nat. Rev. Cancer · 2011 · 11 · 5910.1038/nrc2966 ↗
8. Wang J. · AAPS J. · 2010 · 12 · 49210.1208/s12248-010-9210-4 ↗
9. Rettig G. R. · Mol. Ther. · 2012 · 20 · 48310.1038/mt.2011.263 ↗
10. Alabi C. · Curr. Opin. Pharm. · 2012 · 12 · 42710.1016/j.coph.2012.05.004 ↗
11. Kesharwani P. · Biomaterials · 2012 · 33 · 713810.1016/j.biomaterials.2012.06.068 ↗
12. Zhou J. · Pharmaceuticals · 2013 · 6 · 8510.3390/ph6010085 ↗
13. Dokka S. · Pharm. Res. · 2000 · 17 · 52110.1023/A:1007504613351 ↗
14. Filion M. C. · Biochim. Biophys. Acta, Biomembr. · 1997 · 1329 · 34510.1016/S0005-2736(97)00126-0 ↗
15. Lv H. · J. Controlled Release · 2006 · 114 · 10010.1016/j.jconrel.2006.04.014 ↗
16. Soenen S. J. H. · Biomaterials · 2009 · 30 · 369110.1016/j.biomaterials.2009.03.040 ↗
17. Akhtar S. · Adv. Drug Delivery Rev. · 2007 · 59 · 16410.1016/j.addr.2007.03.010 ↗
18. Ballarin-Gonzalez B. · Adv. Drug Delivery Rev. · 2012 · 64 · 171710.1016/j.addr.2012.07.004 ↗
19. Abes R. · Biochem. Soc. Trans. · 2007 · 35 · 77510.1042/BST0350775 ↗
20. Hassane F. S. · Cell. Mol. Life Sci. · 2010 · 67 · 71510.1007/s00018-009-0186-0 ↗
21. Morris M. C. · Biol. Cell · 2008 · 100 · 20110.1042/BC20070116 ↗
22. Meade B. R. · Adv. Drug Delivery Rev. · 2008 · 60 · 53010.1016/j.addr.2007.10.004 ↗
23. Endoh T. · Adv. Drug Delivery Rev · 2009 · 61 · 70410.1016/j.addr.2009.04.005 ↗
24. Laufer S. D. · 2010 · 2910.1007/978-3-642-12168-5_2 ↗
25. Hoyer J. · Acc. Chem. Res. · 2012 · 45 · 104810.1021/ar2002304 ↗
26. Nakase I. · Acc. Chem. Res. · 2012 · 45 · 113210.1021/ar200256e ↗
27. Veldhoen S. · Int. J. Mol. Sci. · 2008 · 9 · 127610.3390/ijms9071276 ↗
28. Trabulo S. · Pharmaceuticals · 2010 · 3 · 96110.3390/ph3040961 ↗
29. Lundberg P. · FASEB J. · 2007 · 21 · 266410.1096/fj.06-6502com ↗
30. Lo S. L. · Biomaterials · 2008 · 29 · 240810.1016/j.biomaterials.2008.01.031 ↗
31. Chiu Y.-L. · Chem. Biol. · 2004 · 11 · 116510.1016/j.chembiol.2004.06.006 ↗
32. Shiraishi T. · Nat. Protoc. · 2006 · 1 · 63310.1038/nprot.2006.92 ↗
33. Wooddell C. I. · Mol. Ther. · 2013 · 21 · 97310.1038/mt.2013.31 ↗
34. van Asbeck A. H. · ACS Nano · 2013 · 7 · 379710.1021/nn305754c ↗
35. Hou K. K. · Biomaterials · 2013 · 34 · 311010.1016/j.biomaterials.2013.01.037 ↗
36. Nicolás P. · Acta Biomater. · 2013 · 9 · 475410.1016/j.actbio.2012.09.040 ↗
37. Veldhoen S. · Nucleic Acids Res. · 2006 · 34 · 656110.1093/nar/gkl941 ↗
38. Ivanov A. I. · 2008 · 1510.1007/978-1-59745-178-9_2 ↗
39. Vercauteren D. · Mol. Ther. · 2010 · 18 · 56110.1038/mt.2009.281 ↗
40. Nakase I. · Adv. Drug Delivery Rev. · 2008 · 60 · 59810.1016/j.addr.2007.10.006 ↗
41. Xiao Y.-T. · Int. J. Biochem. Cell Biol. · 2008 · 40 · 200210.1016/j.biocel.2007.08.006 ↗
42. Merion M. · Proc. Natl. Acad. Sci. U.S.A. · 1983 · 80 · 531510.1073/pnas.80.17.5315 ↗
43. Eissenberg L. G. · J. Exp. Med. · 1993 · 177 · 160510.1084/jem.177.6.1605 ↗
44. Chou S. T. · Cancer Gene Ther. · 2011 · 18 · 70710.1038/cgt.2011.40 ↗
45. Langlet-Bertin B. · Pharm. Res. · 2010 · 27 · 142610.1007/s11095-010-0138-2 ↗
46. Pichon C. · Nucleic Acids Res. · 2000 · 28 · 50410.1093/nar/28.2.504 ↗
47. Tanaka K. · Int. J. Pharm. · 2010 · 398 · 21910.1016/j.ijpharm.2010.07.038 ↗
48. Yu W. · Nucleic Acids Res. · 2004 · 32 · e4810.1093/nar/gnh049 ↗
49. Krogstad D. J. · Biochem. Pharmacol. · 1986 · 35 · 54710.1016/0006-2952(86)90345-X ↗
50. Caron N. J. · Biochem. Biophys. Res. Commun. · 2004 · 319 · 1210.1016/j.bbrc.2004.04.180 ↗
51. Alabi C. A. · ACS Nano · 2012 · 6 · 613310.1021/nn3013838 ↗
52. Geoghegan J. C. · Mol. Ther.—Nucleic Acids · 2012 · 1 · e5310.1038/mtna.2012.43 ↗
53. Rauch D. A. · Viruses · 2011 · 3 · 88610.3390/v3060886 ↗
54. Keutgens A. · Biochem. Pharmacol. · 2006 · 72 · 106910.1016/j.bcp.2006.06.011 ↗
55. Horie R. · Int. Rev. Immunol. · 2007 · 26 · 26910.1080/08830180701703364 ↗
56. Dewan M. Z. · J. Virol. · 2003 · 77 · 528610.1128/JVI.77.9.5286-5294.2003 ↗
57. Mori N. · Blood · 2002 · 100 · 182810.1182/blood-2002-01-0151 ↗
58. Shu S. T. · Cancer Res. · 2007 · 67 · 1185910.1158/0008-5472.CAN-07-1701 ↗
59. Mitra-Kaushik S. · Blood · 2004 · 104 · 80210.1182/blood-2003-11-3967 ↗
60. Hajj H. E. · J. Exp. Med. · 2010 · 207 · 278510.1084/jem.20101095 ↗
61. Watanabe M. · Blood · 2005 · 106 · 246210.1182/blood-2004-09-3646 ↗
62. Shi B. · J. Histochem. Cytochem. · 2011 · 59 · 72710.1369/0022155411410885 ↗
63. Zuckerman J. E. · Proc. Natl. Acad. Sci. U.S.A. · 2012 · 109 · 313710.1073/pnas.1200718109 ↗
64. Thiele L. · Biomaterials · 2003 · 24 · 140910.1016/S0142-9612(02)00525-2 ↗
65. Ogawara K.-I. · J. Controlled Release · 2004 · 100 · 45110.1016/j.jconrel.2004.07.028 ↗
66. Bernal-Mizrachi L. · Proc. Natl. Acad. Sci. U.S.A. · 2006 · 103 · 922010.1073/pnas.0507809103 ↗
67. Kitajima I. · Science · 1992 · 258 · 179210.1126/science.1299224 ↗
68. Raper S. E. · Mol. Genet. Metab. · 2003 · 80 · 14810.1016/j.ymgme.2003.08.016 ↗
69. Hacein-Bey-Abina S. · Science · 2003 · 302 · 41510.1126/science.1088547 ↗
70. Ahn M. · Hum. Gene Ther. · 2011 · 22 · 148310.1089/hum.2010.234 ↗
71. Rauch D. · Blood · 2009 · 113 · 149310.1182/blood-2008-07-166462 ↗